Here we explain that nearly 1/4 of Americans risk being harmed by a dose threshold of 90mme and ask that the FDA tracks patient outcomes for any change in definition of MME or utilization of ‘guideline’ based on the deeply flawed concept of one MME calculation.
I will upload a better version of this and other presentations as they become available. This conference has so much information that we feel understanding how varied and flawed the concept of MME is critical to our issue.
This was a huge moment for our cause!
This is the busiest time of year for legislative work! Help fund P3 while we juggle legislative studies, bill drafting deadlines across the country, and political events.